Mária Nagyová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mária Nagyová has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Emil Pilipčinec
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
1 shared publication - Gabriela Gregová
Department of Public Veterinary Medicine and Animal Welfare, the University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
1 shared publication - Ján Király
Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice, 041 81 Kosice, Slovakia
1 shared publication - Nikola Dančová
Department of Public Veterinary Medicine and Animal Welfare, the University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
1 shared publication - Patrícia Hudecová
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
1 shared publication - Simona Hisirová
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
1 shared publication
Latest Publications
- Open Access
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2449
Characterization and Antimicrobial Resistance Profiles of Biofilm Forming Strains of Staphylococcus aureus Isolated from Skin Lesions
Staphylococcus aureus is an important human pathogen known for its versatility and ability to cause a wide range of infections. The aim of this study was to isolate and identify S. aureus from skin lesions from human patients, to determine antimicrobial resistance and biofilm formation potential at phenotypic and genotypic levels, as well as to verify the activity of efflux pump production. Out of 51 samples collected from skin lesions of various etiologies, 13 isolates were identified as S. aureus. All isolates showed the ability to form biofilms, which correlated with the presence of the icaABCD, agrA, srtA, clfAB, and fnbAB genes, while the bap gene was absent. The highest rates of resistance were observed for ampicillin (69.2%) and gentamicin (46.2%), as well as for erythromycin and clindamycin (38.5%). The mecA gene was present in two isolates, but phenotypic resistance to methicillin was confirmed in only one of them, suggesting possible heterogeneous expression or regulated activity of resistance mechanisms. The mecC gene was not present in any isolate. Efflux pump production was observed in only three isolates, showing weak to intermediate levels. These findings indicate the high biofilm potential and variable antimicrobial resistance of S. aureus clinical isolates, which pose a challenge for the treatment of emerging skin infections.
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2449
Open AccessCharacterization and Antimicrobial Resistance Profiles of Biofilm Forming Strains of Staphylococcus aureus Isolated from Skin Lesions
Staphylococcus aureus is an important human pathogen known for its versatility and ability to cause a wide range of infections. The aim of this study was to isolate and identify S. aureus from skin lesions from human patients, to determine antimicrobial resistance and biofilm formation potential at phenotypic and genotypic levels, as well as to verify the activity of efflux pump production. Out of 51 samples collected from skin lesions of various etiologies, 13 isolates were identified as S. aureus. All isolates showed the ability to form biofilms, which correlated with the presence of the icaABCD, agrA, srtA, clfAB, and fnbAB genes, while the bap gene was absent. The highest rates of resistance were observed for ampicillin (69.2%) and gentamicin (46.2%), as well as for erythromycin and clindamycin (38.5%). The mecA gene was present in two isolates, but phenotypic resistance to methicillin was confirmed in only one of them, suggesting possible heterogeneous expression or regulated activity of resistance mechanisms. The mecC gene was not present in any isolate. Efflux pump production was observed in only three isolates, showing weak to intermediate levels. These findings indicate the high biofilm potential and variable antimicrobial resistance of S. aureus clinical isolates, which pose a challenge for the treatment of emerging skin infections.